California Nanotechnologies Corp. Stocks

$ 0.19Last Updated 15.04.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 9.03M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.19
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

California Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction. The company provides spark plasma/ field assisted sintering (SPS/FAST); hot pressing; sintering; diffusion bonding; hot isostatic pressing; vacuum pressureless sintering; cryogenic milling, inert gas milling, planetary ball milling, and pulverizing; and material development and testing services, including mechanical alloying, composites/non-composites, mechanical testing, sample fabrication, prototyping, scanning electron microscopy analysis, and particle size analysis. It also offers SPS starter accessory kits, SPS graphite tooling, SPS systems, tungsten carbide tooling, SPS graphite crucibles, carbon graphite foil/paper, carbon felt and yarn, and quartz glass windows; and Engemini, an SPS/FAST modeling software. It serves aerospace, defense, automotive, medical, and sports and recreation industries. The company is headquartered in Cerritos, California.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks